View in EDS

Ruxolitinib cream for the treatment of vitiligo - Authors' reply.

Saved in:
Bibliographic Details
Title: Ruxolitinib cream for the treatment of vitiligo - Authors' reply.
Authors: Rosmarin D; Tufts Medical Center, Boston, MA 02111, USA. Electronic address: drosmarin@tuftsmedicalcenter.org., Butler K; Incyte Corporation, Wilmington, DE, USA., Kuo F; Incyte Corporation, Wilmington, DE, USA., Harris JE; University of Massachusetts Medical School, Worcester, MA, USA.
Source: Lancet (London, England) [Lancet] 2020 Nov 28; Vol. 396 (10264), pp. 1736.
Publication Type: Letter; Comment
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33248494
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ruxolitinib cream for the treatment of vitiligo - Authors' reply.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rosmarin+D%22">Rosmarin D</searchLink>; Tufts Medical Center, Boston, MA 02111, USA. Electronic address: drosmarin@tuftsmedicalcenter.org.<br /><searchLink fieldCode="AU" term="%22Butler+K%22">Butler K</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Kuo+F%22">Kuo F</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Harris+JE%22">Harris JE</searchLink>; University of Massachusetts Medical School, Worcester, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2020 Nov 28; Vol. 396 (10264), pp. 1736.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33248494
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(20)32470-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1736
    Titles:
      – TitleFull: Ruxolitinib cream for the treatment of vitiligo - Authors' reply.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rosmarin D
      – PersonEntity:
          Name:
            NameFull: Butler K
      – PersonEntity:
          Name:
            NameFull: Kuo F
      – PersonEntity:
          Name:
            NameFull: Harris JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 11
              Text: 2020 Nov 28
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 396
            – Type: issue
              Value: 10264
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1